Evaluation of the measles clinical case definition

被引:53
作者
Hutchins, SS
Papania, MJ
Amler, R
Maes, EF
Grabowsky, M
Bromberg, K
Glasglow, V
Speed, T
Bellini, WJ
Orenstein, WA
机构
[1] Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Epidemiol Program Off, Atlanta, GA 30333 USA
[3] Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA 30333 USA
[4] Morehouse Coll, Project IMHOTEP, Atlanta, GA USA
[5] Agcy Tox Subst & Dis Registry, Off Childrens Hlth, Atlanta, GA USA
[6] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA
[7] Caribbean Epidemiol Res Ctr, Lab Serv, Port Of Spain, Trinidad Tobago
关键词
D O I
10.1086/379652
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
An accurate system of identifying and classifying suspected measles cases is critical for the measles surveillance system in the United States. To examine the performance of the clinical case definition in predicting laboratory confirmation of suspected cases of measles, we reviewed 4 studies conducted between 1981 and 1994. A clinical case definition was examined that included a generalized maculopapular rash, fever (greater than or equal to38.3degreesC, if measured), and either a cough, coryza, or conjunctivitis. Serological confirmation of measles was done either by hemagglutination inhibition assay, complement fixation assay, or enzyme immunoassays. The positive predictive value of the clinical case definition decreased from 74% to 1% as incidence decreased from 171 cases/100,000 population to 1.3 cases/100,000 population. Sensitivity was high, and for the larger studies with the most precise estimates, sensitivity was 76%-88%. The low positive predictive value of the clinical case definition in settings of low incidence demonstrates that serological confirmation is essential to ensure an accurate diagnosis of measles when measles is rare.
引用
收藏
页码:S153 / S159
页数:7
相关论文
共 18 条
[11]   Review of regional measles surveillance data in the Americas, 1996-99 [J].
Hersh, BS ;
Tambini, G ;
Nogueira, AC ;
Carrasco, P ;
de Quadros, CA .
LANCET, 2000, 355 (9219) :1943-1948
[12]   BACULOVIRUS EXPRESSION OF THE NUCLEOPROTEIN GENE OF MEASLES-VIRUS AND UTILITY OF THE RECOMBINANT PROTEIN IN DIAGNOSTIC ENZYME IMMUNOASSAYS [J].
HUMMEL, KB ;
ERDMAN, DD ;
HEATH, J ;
BELLINI, WJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (11) :2874-2880
[13]   Vaccine-modified measles in previously immunized children in Accra, Ghana: clinical, virological and serological parameters [J].
Ishiwada, N ;
Addae, MM ;
Tetteh, JKA ;
Yempewu, SM ;
Ofori-Adjei, D ;
Kamiya, H ;
Akanmori, BD .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2001, 6 (09) :694-698
[14]  
MEHTA C, 1996, STATXACT 3 WINDOWS
[15]  
PAPANIA M, 1996, 36 INT C ANT CHEM NE
[16]  
Ratnam S, 2000, J CLIN MICROBIOL, V38, P99
[17]  
Redd SC, 1999, Vaccines, P222
[18]  
ROMAGUERA RA, 2001, PRINCIPLES PRACTICE, P176